Search Results 621-630 of 18356 for Lactation
Participation eligibility · Is pregnant or lactating · Concurrent regular use of another leukotriene pathway inhibitor · Any reason that, in the opinion of the ...
Female patients must have negative urine pregnancy tests and must not be lactating. For females able to bear children, a hormonal (i.e., oral, implantable ...
Pregnant and lactating women; History of autoimmune disease; History of idiopathic pulmonary fibrosis, organizing pneumonia, drug-induced pneumonitis ...
Lactating females are not eligible unless they have agreed not to breastfeed their infants; Female patients of childbearing potential are not eligible unless ...
Pregnant, intending to become pregnant during the study, or currently breastfeeding/lactating. 22. Any unstable disease, intercurrent illness, abnormality ...
A female patient who is pregnant or lactating 12. Patient is unwilling or unable to comply with the scheduled visits, drug administration plan, laboratory ...
Lactating woman must interrupt breastfeeding and pump and discard breast milk during and for 20 days after last administration of study intervention.
Women who are pregnant or lactating. Women of childbearing potential or fertile men unwilling to use highly effective contraception during study and up to ...
This medicine is used to treat patients with H. pylori infection and duodenal ulcers caused by H. pylori bacteria. Lansoprazole is a proton pump inhibitor (PPI) ...
If female, the patient is pregnant or lactating. Known allergy or hypersensitivity to any component of the investigational drug product. Patients with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.